Thus, Hmgb2 is a promising target for therapeutic intervention of stroke as inhibition of Hmgb2 selectively blocks microglia pro-inflammatory signals blocked while preserving microglia anti-inflammatory functions. This evidence concerns the gene HMGB2 and stroke disorder.